1. Laparoscopic complete urinary tract exenteration with the specimen withdrawn transvaginally
- Author
-
Yii-Her Chou, Chia-Chu Liu, Shu-Pin Huang, Chun-Hsiung Huang, Yung-Shun Juan, Shih-Cheng Hus, Ching-Chia Li, Mei-Yu Jang, Hsun-Shuan Wang, Cheng-Yu Long, Chieh-Han Chuang, and Wen-Jeng Wu
- Subjects
Urologic Neoplasms ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,Urinary system ,Hysterectomy ,Nephrectomy ,Specimen Handling ,Postoperative Complications ,Cystourethrectomy ,medicine ,Humans ,Radical Hysterectomy ,Urinary Tract ,Laparoscopy ,Aged ,Uremia ,medicine.diagnostic_test ,Pelvic exenteration ,business.industry ,Length of Stay ,Middle Aged ,medicine.disease ,Surgery ,Endoscopy ,Treatment Outcome ,medicine.anatomical_structure ,Vagina ,Feasibility Studies ,Urologic Surgical Procedures ,Female ,business ,Kidney disease - Abstract
OBJECTIVE To describe the technique of laparoscopic complete urinary tract exenteration (LaCUTE), where specimens are withdrawn en bloc through the vagina, and to compare our results for patients had this procedure with those who had surgery by traditional open methods PATIENTS AND METHODS From February 2006 to June 2008, five patients had LaCUTE and three CUTE at our institute. The surgical procedure included bilateral nephroureterectomy, bilateral pelvic lymphadenectomy, radical cystourethrectomy, radical hysterectomy, bilateral salpingo-oophorectomy. RESULTS In the LaCUTE group the mean (range) patient age was 58 (46–73) years, the blood loss was 378 (290–490) mL, the operative duration was 492 (405–560) min and the hospital stay was 12.2 (9–17) days. All patients had negative surgical margins on pathological examination. The LaCUTE group had significantly less blood loss but longer surgery than the open group. At a mean follow-up of 14.5 and 16.0 months, respectively, there was no evidence of recurrent cancer in both groups. CONCLUSIONS With further experience and improvement in surgical techniques, LaCUTE with vaginal specimen en bloc withdrawal will become feasible for uraemic female patients with urothelial cancer.
- Published
- 2009
- Full Text
- View/download PDF